Your browser doesn't support javascript.
loading
Targeting endothelial thioredoxin-interacting protein (TXNIP) protects from metabolic disorder-related impairment of vascular function and post-ischemic revascularisation.
Domingues, Alison; Boisson-Vidal, Catherine; Marquet de Rouge, Perrine; Dizier, Blandine; Sadoine, Jérémy; Mignon, Virginie; Vessières, Emilie; Henrion, Daniel; Escriou, Virginie; Bigey, Pascal; Chaussain, Catherine; Smadja, David M; Nivet-Antoine, Valérie.
Afiliação
  • Domingues A; INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, 75006, Paris, France.
  • Boisson-Vidal C; INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, 75006, Paris, France.
  • Marquet de Rouge P; INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, 75006, Paris, France.
  • Dizier B; INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, 75006, Paris, France.
  • Sadoine J; EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, Dental School, Université de Paris, 92120, Montrouge, France.
  • Mignon V; PTICM, CNRS, INSERM 3612, Université de Paris, 75006, Paris, France.
  • Vessières E; CNRS, INSERM 1083, MITOVASC, Université Angers, 49045, Angers, France.
  • Henrion D; CNRS, INSERM 1083, MITOVASC, Université Angers, 49045, Angers, France.
  • Escriou V; CNRS, Unité de Technologies Chimiques et Biologiques pour la santé (UTCBS), UMR 8258, INSERM 1022, Université de Paris, Chimie Paris Tech, 75006, Paris, France.
  • Bigey P; CNRS, Unité de Technologies Chimiques et Biologiques pour la santé (UTCBS), UMR 8258, INSERM 1022, Université de Paris, Chimie Paris Tech, 75006, Paris, France.
  • Chaussain C; EA 2496, Laboratory of Orofacial Pathologies, Imaging and Biotherapies, Dental School, Université de Paris, 92120, Montrouge, France.
  • Smadja DM; Odontology Department, AP-HP, Bretonneau Hospital, 75018, Paris, France.
  • Nivet-Antoine V; INSERM 1140, Innovative Therapies in Haemostasis, Faculty of Pharmacy, Université de Paris, 75006, Paris, France.
Angiogenesis ; 23(2): 249-264, 2020 05.
Article em En | MEDLINE | ID: mdl-31900750
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiorredoxinas / Proteínas de Transporte / Neovascularização Fisiológica / Células Endoteliais / Isquemia / Doenças Metabólicas Limite: Animals Idioma: En Revista: Angiogenesis Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tiorredoxinas / Proteínas de Transporte / Neovascularização Fisiológica / Células Endoteliais / Isquemia / Doenças Metabólicas Limite: Animals Idioma: En Revista: Angiogenesis Assunto da revista: HEMATOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: França